ArticleOncoimmunology2025

Efficacy of anti-LAG3 and anti-PD-1 combination checkpoint inhibitor therapy against head and neck squamous cell carcinoma in a genetically engineered mouse model.

Felipe F Lamenza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.